100 related articles for article (PubMed ID: 19137788)
41. [Correlation of p16/INK4a gene damages and protein expression in the tumor tissue of sporadic breast cancer].
Nemtsova MV; Zemliakova VV; Kuznetsova EV; Popova OP; Zavalishina LE; Frank GA; Zaletaev DV
Arkh Patol; 2008; 70(4):6-9. PubMed ID: 18807517
[TBL] [Abstract][Full Text] [Related]
42. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
Harper DM
Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
[TBL] [Abstract][Full Text] [Related]
43. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
44. Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.
Walker F; Abramowitz L; Benabderrahmane D; Duval X; Descatoire V; Hénin D; Lehy T; Aparicio T
Hum Pathol; 2009 Nov; 40(11):1517-27. PubMed ID: 19716155
[TBL] [Abstract][Full Text] [Related]
45. Human papillomavirus in early laryngeal carcinoma.
Baumann JL; Cohen S; Evjen AN; Law JH; Vadivelu S; Attia A; Schindler JS; Chung CH; Wirth PS; Meijer CJ; Snijders PJ; Yarbrough WG; Slebos RJ
Laryngoscope; 2009 Aug; 119(8):1531-7. PubMed ID: 19489068
[TBL] [Abstract][Full Text] [Related]
46. [Detection of multiple human papillomavirus infection in cervical specimens by flow fluorescent hybridization].
Chen QY; Bian ML; Zhang XY; Ou H; Ma L
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):901-5. PubMed ID: 19671291
[TBL] [Abstract][Full Text] [Related]
47. Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung.
Weichert W; Schewe C; Denkert C; Morawietz L; Dietel M; Petersen I
Am J Surg Pathol; 2009 Apr; 33(4):513-20. PubMed ID: 19145203
[TBL] [Abstract][Full Text] [Related]
48. Adding the p16(INK4a) marker to the traditional 3-marker (ER/Vim/CEA) panel engenders no supplemental benefit in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Han CP; Lee MY; Kok LF; Ruan A; Wu TS; Cheng YW; Tyan YS; Lin CY
Int J Gynecol Pathol; 2009 Sep; 28(5):489-96. PubMed ID: 19696622
[TBL] [Abstract][Full Text] [Related]
49. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
50. Transition of cervical carcinoma in situ to invasive cancer: role of p16 INK4a expression in progression and in recurrence.
Anschau F; Schmitt VM; Lambert AP; Gonçalves MA; Machado DC
Exp Mol Pathol; 2009 Feb; 86(1):46-50. PubMed ID: 19100258
[TBL] [Abstract][Full Text] [Related]
51. P16 immunostaining patterns in microglandular hyperplasia of the cervix and their significance.
Roh MH; Agoston E; Birch C; Crum CP
Int J Gynecol Pathol; 2009 Mar; 28(2):107-13. PubMed ID: 19188826
[TBL] [Abstract][Full Text] [Related]
52. Comparison between the Hybrid Capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia.
Gustavsson I; Juko-Pecirep I; Backlund I; Wilander E; Gyllensten U
J Clin Virol; 2009 Jun; 45(2):85-9. PubMed ID: 19451022
[TBL] [Abstract][Full Text] [Related]
53. Abnormal cervical cytology is associated with increased nitric oxide release in the uterine cervix.
Rahkola P; Mikkola TS; Nieminen P; Ylikorkala O; Vaisanen-Tommiska M
Acta Obstet Gynecol Scand; 2009; 88(4):417-21. PubMed ID: 19266358
[TBL] [Abstract][Full Text] [Related]
54. Ancillary p16(INK4a) adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Yao CC; Kok LF; Lee MY; Wang PH; Wu TS; Tyan YS; Cheng YW; Kung MF; Han CP
Arch Gynecol Obstet; 2009 Sep; 280(3):405-13. PubMed ID: 19153755
[TBL] [Abstract][Full Text] [Related]
55. The role of HPV testing in patients with possible high-grade cervical cytology.
Rao A; Pather S; Dalrymple C; Mackie A; Deans R; Carter J
J Obstet Gynaecol Res; 2009 Jun; 35(3):503-6. PubMed ID: 19527390
[TBL] [Abstract][Full Text] [Related]
56. AgNOR technique could be useful for differential diagnosis of squamous carcinomatous cells and atypical cells related to human papillomavirus in cervical smears.
Palaoro L; Rocher A
Biotech Histochem; 2009 Jun; 84(3):73-8. PubMed ID: 19333799
[TBL] [Abstract][Full Text] [Related]
57. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
58. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
Leong WF; Chau JF; Li B
Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
[TBL] [Abstract][Full Text] [Related]
59. Biomarker p16(INK4a) on paraffin sections from residual material: cancerous tissue fragments overlooked in false negative papanicolaou-stained thin-layer slide.
Boon ME; Risse EK; Ouwerkerk-Noordam E
Acta Cytol; 2009; 53(2):239-40. PubMed ID: 19365985
[No Abstract] [Full Text] [Related]
60. [Diagnostic importance of ProEx C in gynecologic cytopathology].
Tambouret RH
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S92-3. PubMed ID: 18984316
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
